News

A Labor of Love to Engage and Inform: 25 Years of the Bay Area Breast Cancer Forum

For Some Prostate Cancer Patients, PSMA PET May Be Better for Initial Staging of Disease

A recent article in the Journal of Nuclear Medicine reports findings of a multi-center retrospective study that compares bone scan with PSMA PET for initial staging of prostate cancer. Authors include UCSF Radiology and Biomedical Imaging faculty members Thomas Hope, MD, Roxanna Juarez, MD, Miguel

Susan Chang on Serving as Editor-in-Chief for Neuro-Oncology

Last March, the Society for Neuro-Oncology (SNO) and Oxford University Press named UCSF neuro-oncologist Susan Chang, MD, Editor-in-Chief of its flagship journal Neuro-Oncology. Since then, she has overseen an increase in the journal’s impact factor from 13.029 to 15.9, making it among the most

Celebrating Postdoc Appreciation Week: Q&A with Shalini Chopra, PhD, and Apurva Pandey, PhD

I'm thrilled that Drs. Chopra and Pandey are being recognized by SNMMI for their innovative research. This prestigious honor is well deserved, as both are exceedingly gifted scientists of the highest character and professionalism. I anticipate this will be one of many future recognitions from their

150 Milestone: Robotic Procedure Changes Prostate Cancer Care

UCSF Health has performed 150 robotic focal high-intensity focused ultrasound (HIFU) procedures for patients living with prostate cancer, becoming the first on the West Coast and the first UC Health System to reach that milestone. The HIFU technology uses ultrasound waves to destroy cancerous

From AI to Cancer, Arc Institute Supports Curiosity-Driven Science at UCSF

Discoveries result from a mix of smarts, creativity, grit, collaboration, serendipity and time. But when scientists must constantly apply for funding, that last factor can be hard to come by. The Arc Institute, a privately-funded research organization in Palo Alto is hoping to fill that gap with

CRISPR Cures for Cancer: Partnership to Accelerate Cell Therapy Using Genomics

Announcing the launch of CRISPR Cures for Cancer, a tri-institutional initiative between UCSF, Gladstone Institutes, and the Innovative Genomics Institute at UC Berkeley, which aims to accelerate cell therapy design and development using genomic technologies. CRISPR Cures for Cancer Initiative is